MWG Management Ltd.
CIK
1845151
Location
London, X0
Portfolio Value
Micro
$81,319,134
Diversification
Highly concentrated
Filing Date
Global Rank
#5,920
/ 7,986
▲ 726
· as of Sep 2025
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-27.7%
Period ended 9 months ago
Filed Nov 12, 2025 · 8mo
20 quarters · since Dec 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-7.0%
SPY
+76.0%
Annualised alpha
-23.1%
Max drawdown
−70.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
3 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
67.7%
−22.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
5,132
Highly concentrated−3,021
Portfolio Trend
20 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $81,319,134 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | 1,008,116 | $16,371,803 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
3 positions ·
$81,319,134 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Held | 2,266,934 | $55,018,488 | 67.66% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
NEW | 1,008,116 | $16,371,803 | 20.13% | |
| PRME |
Prime Medicine, Inc.
Healthcare
|
Held | 1,792,210 | $9,928,843 | 12.21% |